Thienopyranones as kinase inhibitors
US8557807B2 · kind B2 · utility
7Cited by
6References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 23, 2009 |
| Grant date | Oct 15, 2013 |
| Priority date | — |
| Expiry date | Jan 23, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K5/1019
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention, relates to compounds of formula I (or pharmaceutically acceptable salts thereof) as defined herein, pharmaceutical compositions thereof, and their use in manufactures and methods for modulating biological processes including inhibition of kinase activity such as P1-3 kinase.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.